Related Experiment Video
Updated: Aug 5, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Stress-specific 14-3-3-client modules in digestive cancers: an evidence-graded review of adaptive survival and
Rudong Li1, Zhipeng Zhao1, Xudong Wang1
1Department of Gastrointestinal Nutrition and Hernia Surgery, The Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
Abstract:
14-3-3 proteins are phosphoserine- and phosphothreonine-binding adaptors that regulate client localization, stability and activity under cellular stress. This narrative review synthesizes stress-specific 14-3-3-client modules in gastric, colorectal, pancreatic, hepatocellular and biliary cancers. Modules were classified as high, moderate, early/context-dependent or background according to mechanistic evidence, functional perturbation, client mapping, treatment-state validation and clinical association. In gastric cancer, G3BP stress granule assembly factor 1 (G3BP1) cooperates with YWHAZ-encoded 14-3-3ζ to retain pro-apoptotic Bax in the cytoplasm. In colorectal cancer, SFN-encoded 14-3-3σ restricts Yin Yang 1 (YY1), sustaining the unfolded protein response and chemotherapy tolerance. In pancreatic cancer, SFN-encoded 14-3-3σ interacts with Yes-associated protein 1 (YAP1) to promote ribonucleotide reductase expression and gemcitabine resistance. In hepatobiliary cancers, SFN-related modules support anoikis resistance but remain context dependent. Clinically relevant units are stress-specific 14-3-3-client complexes rather than total 14-3-3 expression.
Insights
Stress-specific 14-3-3 protein interactions, not total levels, are key in cancers. These modules influence cell death, stress responses, and treatment resistance across various gastrointestinal cancers.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Stress Response
Background:
- 14-3-3 proteins are crucial adaptors regulating cellular processes under stress.
- Dysregulation of 14-3-3 interactions is implicated in various cancers.
- Understanding specific 14-3-3-client modules is vital for cancer research.
Purpose of the Study:
- To review and synthesize stress-specific 14-3-3 protein-client interactions in major gastrointestinal cancers.
- To classify these modules based on mechanistic and clinical evidence.
- To highlight the clinical relevance of specific complexes over total protein expression.
Main Methods:
- Narrative review of existing literature.
- Classification of 14-3-3-client modules based on mechanistic evidence, functional perturbation, client mapping, treatment-state validation, and clinical association.
- Synthesis of findings across gastric, colorectal, pancreatic, and hepatobiliary cancers.
Main Results:
- Identified distinct stress-specific 14-3-3-client modules in gastric, colorectal, and pancreatic cancers.
- In gastric cancer, 14-3-3ζ-G3BP1 retains Bax, inhibiting apoptosis.
- In colorectal cancer, 14-3-3σ-SFN sustains unfolded protein response and chemoresistance.
- In pancreatic cancer, 14-3-3σ-SFN promotes gemcitabine resistance via YAP1 and ribonucleotide reductase.
- Hepatobiliary cancer modules show context-dependent anoikis resistance.
Conclusions:
- Clinically relevant units are stress-specific 14-3-3-client complexes, not overall 14-3-3 expression levels.
- These specific modules play significant roles in cancer progression and treatment response.
- Targeting these defined modules offers potential therapeutic strategies in gastrointestinal cancers.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...